Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer [Phase 3]
Phase 3 clinical trial evaluating radiotherapy for CA19-9–elevated advanced pancreatic cancer; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: CT-95 in Advanced Cancers Associated With Mesothelin Expression [Phase 1]
Phase 1 trial CT-95 for mesothelin-expressing tumors is currently recruiting across multiple indications, including epithelial ovarian cance…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: DCE MRI in Patients With Pancreatic Cancer [NA]
A terminated clinical trial evaluating dynamic contrast-enhanced MRI in patients with pancreatic cancer, including familial pancreatic cance…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Maintenance With Olaparib or Selumetinib + Durvaluma for m-PDAC Guided by BRCAness and KRAS Status. [Phase 2]
Phase 2 trial evaluating maintenance therapy with olaparib or selumetinib in combination with durvalumab for metastatic pancreatic adenocarc…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/Phase 2 study of Y101D in combination with gemcitabine and nab-paclitaxel for advanced pancreat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) [Phase 1, Phase 2]
Clinical trial update for Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) in Phase 1/Phase 2, currently recruiting…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Contribution of New Pancreatic MRI Sequences for the Evaluation of Tumor Response in Pancreatic Adenocarcinomas [NA]
A clinical trial evaluating novel pancreatic MRI sequences to assess tumor response in pancreatic adenocarcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Adjuvant Pancreatic Therapy Guided by MRD [NA]
A registered clinical trial investigating adjuvant pancreatic therapy guided by minimal residual disease (MRD) in resectable pancreatic aden…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: A Beta-only IL-2 ImmunoTherapY Study [Phase 1, Phase 2]
Medicennа Therapeutics is evaluating a beta-only IL-2 immunotherapy (MDNA11) in Phase 1/2 across multiple advanced solid tumors; recruitment…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma [Phase 1]
This Phase 1 trial evaluates pressure-enabled intrapancreatic delivery of SD-101 in combination with checkpoint blockade for locally advance…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma [Phase 2]
Phase 2 study evaluating an adaptive neoadjuvant therapy approach to maximize surgical resection rates in pancreatic adenocarcinoma. The tri…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: 1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma [Phase 2]
This document updates on a phase 2 clinical trial evaluating galeterone in combination with gemcitabine for metastatic pancreatic adenocarci…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Proteomic Profiling to Differentiate Pancreatic and Biliary Adenocarcinomas
This clinical trial update outlines a study using proteomic profiling to differentiate pancreatic adenocarcinoma from biliary adenocarcinoma…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial update notes that a Chemo4METPANC regimen combining a chemokine inhibitor, immunotherapy, and chemotherapy is curre…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) [Phase 2]
Phase 2 clinical trial update from Duke University on preventing progression from intraductal papillary mucinous neoplasm to pancreatic canc…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Management of Symptomatic Advanced Pancreatic Adenocarcinoma [NA]
This update notes a GERCOR-sponsored trial on management and supportive care for symptomatic advanced pancreatic adenocarcinoma, currently A…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients [NA]
Clinical trial update showing a first-line gemcitabine regimen (GemCore+) for metastatic pancreatic adenocarcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors [Phase 1]
BA1302 from Shandong Boan Biotechnology Co., Ltd is in Phase 1 testing for advanced solid tumors, with non-small cell lung cancer, pancreati…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial evaluating stimulation with bethanechol in combination with gemcitabine and nab-paclitaxel for pancreatic adenocarc…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating hypofractionated stereotactic body radiation therapy with 5-fluorouracil or capecitabine for locally advan…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer. [Phase 3]
A Phase 3 randomized trial compares switch maintenance with gemcitabine plus nab-paclitaxel to continuation of modified FOLFIRINOX as first-…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma [Phase 1]
A Phase 1 clinical trial is evaluating Th-1 dendritic cell immunotherapy in combination with standard chemotherapy for pancreatic adenocarci…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)
A Cedars-Sinai trial is studying small intestinal bacterial overgrowth in pancreatic adenocarcinoma patients, and it is currently recruiting…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Evaluating Novel Therapies in ctDNA Positive GI Cancers [Phase 3]
Georgetown University is conducting a Phase 3 trial evaluating novel therapies for ctDNA-positive gastrointestinal cancers, currently recrui…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
This entry reports an ongoing Phase 1/2 clinical trial evaluating the combination of avelumab and pepinemab as second-line therapy for metas…